跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
VANDRAL RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA
Approved
STANDARD
VANDRAL RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA
Upjohn Eesv
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 22, 2025
Approval ID
519767e4af81d3ab
Company
Upjohn Eesv
Type
Standard
Approval Details
Approval Id
519767e4af81d3ab
Drug Cima Aemps Name
VANDRAL RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA
Register Number
123042IP
Holder Company Name
Upjohn Eesv
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/upjohn-eesv
Authorization Date
2025-04-22
Dosage Form
CÁPSULA DURA DE LIBERACIÓN PROLONGADA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Upjohn Eesv
Company Detail Path
/organization/upjohn-eesv
Company Information
Pharmaceutical Company Name
Upjohn EESV
Country Name
Netherlands
Active Ingredients
VENLAFAXINA HIDROCLORURO
75 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 22, 2025
Approval ID
519767e4af81d3ab
Type
Standard
Back to CIMA-AEMPS Approvals
VANDRAL RETARD 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details